InterCure Ltd. (INCR)
1.38
0.01 (0.73%)
At close: Apr 17, 2025, 3:57 PM
1.35
-1.72%
After-hours: Apr 17, 2025, 06:30 PM EDT
Company Description
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally.
It offers dried cannabis inflorescences and cannabis extract mixed with oil.
The company also invests in biomed sector.
InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
InterCure Ltd.
| Country | IL |
| IPO Date | Jan 28, 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 270 |
| CEO | Alexander Rabinovich |
Contact Details
Address: 85 Medinat ha-Yehudim Street Herzliya, IL | |
| Website | https://www.intercure.co |
Stock Details
| Ticker Symbol | INCR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001857030 |
| CUSIP Number | M549GJ111 |
| ISIN Number | IL0011063760 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Alexander Rabinovich | Chief Executive Officer & Chairman |
| Amos Cohen | Chief Financial Officer |
| Einat Zehavi | Vice President of Sales |
| Itai Kabiljo | General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 13, 2025 | 6-K | Filing |
| Feb 03, 2025 | 6-K | Filing |
| Jan 31, 2025 | 6-K/A | [Amend] Filing |
| Jan 27, 2025 | 6-K | Filing |
| Dec 30, 2024 | 6-K | Filing |
| Dec 20, 2024 | 6-K | Filing |
| Dec 20, 2024 | 6-K | Filing |
| Nov 25, 2024 | 6-K | Filing |
| Nov 04, 2024 | 6-K | Filing |
| Oct 28, 2024 | 6-K | Filing |